Literature DB >> 27664572

The changing face of cardiovascular disease 2000-2012: An analysis of the world health organisation global health estimates data.

Christopher J McAloon1, Luke M Boylan2, Thomas Hamborg2, Nigel Stallard2, Faizel Osman3, Phang B Lim4, Sajad A Hayat3.   

Abstract

The pattern and global burden of disease has evolved considerably over the last two decades, from primarily communicable, maternal, and perinatal causes to non-communicable disease (NCD). Cardiovascular disease (CVD) has become the single most important and largest cause of NCD deaths worldwide at over 50%. The World Health Organisation (WHO) estimates that 17.6 million people died of CVD worldwide in 2012. Proportionally, this accounts for an estimated 31.43% of global mortality, with ischaemic heart disease (IHD) accounting for approximately 7.4 million deaths, 13.2% of the total. IHD was also the greatest single cause of death in 2000, accounting for an estimated 6.0 million deaths. The global burden of CVD falls, principally, on the low and middle-income (LMI) countries, accounting for over 80% of CVD deaths. Individual populations face differing challenges and each population has unique health burdens, however, CVD remains one of the greatest health challenges both nationally and worldwide.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Epidemiology; Global burden of disease; World Health Organisation

Mesh:

Year:  2016        PMID: 27664572     DOI: 10.1016/j.ijcard.2016.09.026

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  51 in total

Review 1.  2016 Russell Ross Memorial Lecture in Vascular Biology: Molecular-Cellular Mechanisms in the Progression of Atherosclerosis.

Authors:  Ira Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-12-15       Impact factor: 8.311

2.  Intrauterine exposure to diabetes and risk of cardiovascular disease in adolescence and early adulthood: a population-based birth cohort study.

Authors:  Laetitia Guillemette; Brandy Wicklow; Elizabeth A C Sellers; Allison Dart; Garry X Shen; Vernon W Dolinsky; Joseph W Gordon; Davinder S Jassal; Nathan Nickel; Todd A Duhamel; Dan Chateau; Heather J Prior; Jonathan McGavock
Journal:  CMAJ       Date:  2020-09-28       Impact factor: 8.262

3.  Apo A-I (Apolipoprotein A-I) Vascular Gene Therapy Provides Durable Protection Against Atherosclerosis in Hyperlipidemic Rabbits.

Authors:  Bradley K Wacker; Nagadhara Dronadula; Lianxiang Bi; Alexis Stamatikos; David A Dichek
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-11-09       Impact factor: 8.311

4.  High contrast power Doppler imaging in side-viewing intravascular ultrasound imaging via angular compounding.

Authors:  Graham C Collins; Bowen Jing; Brooks D Lindsey
Journal:  Ultrasonics       Date:  2020-06-02       Impact factor: 2.890

5.  Role of Phytoestrogen-Rich Bioactive Substances (Linum usitatissimum L., Glycine max L., Trifolium pratense L.) in Cardiovascular Disease Prevention in Postmenopausal Women: A Systematic Review and Meta-Analysis.

Authors:  Agata Błaszczuk; Agnieszka Barańska; Wiesław Kanadys; Maria Malm; Monika Elżbieta Jach; Urszula Religioni; Rafał Wróbel; Jolanta Herda; Małgorzata Polz-Dacewicz
Journal:  Nutrients       Date:  2022-06-14       Impact factor: 6.706

Review 6.  MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics.

Authors:  Pathricia V Tilstam; Dake Qi; Lin Leng; Lawrence Young; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2017-07       Impact factor: 6.902

Review 7.  The Function and Therapeutic Potential of Circular RNA in Cardiovascular Diseases.

Authors:  Kai Wang; Xiang-Qian Gao; Tao Wang; Lu-Yu Zhou
Journal:  Cardiovasc Drugs Ther       Date:  2021-07-16       Impact factor: 3.727

8.  Seventeen-Year Changes in Body Mass Index, Waist Circumference, Elevated Blood Pressure, and Diabetes Phenotypes in a Cohort of Filipino Women.

Authors:  Linda S Adair; Christopher Kuzawa; Thomas McDade; Delia B Carba; Judith B Borja
Journal:  Asia Pac J Public Health       Date:  2018-09-15       Impact factor: 1.399

Review 9.  The physiological and pathological functions of VEGFR3 in cardiac and lymphatic development and related diseases.

Authors:  Richard M Monaghan; Donna J Page; Pia Ostergaard; Bernard D Keavney
Journal:  Cardiovasc Res       Date:  2021-07-07       Impact factor: 10.787

10.  Blood pressure measurement techniques: Assessing performance in outpatient settings of a tertiary-level hospital in Rwanda.

Authors:  Jean Damascene Kabakambira; Zachee Niyonsenga; Marthe Hategeka; Grace Igiraneza; Genevieve Benurugo; Don Eliseo Lucero-Prisno Iii; Celestin Hategeka
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-05-16       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.